FDA Overseas Clinical Trial Tracking, IRB Inspections Suggested By IG
This article was originally published in The Tan Sheet
Executive Summary
FDA should consider incorporating overseas clinical trial tracking capabilities into domestic databases currently under development, a recent HHS Office of the Inspector General report suggests.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning